Adam M. Koppel
DirectoratSolid Biosciences· In proxies 2023–2024
Adam M. Koppel sits on 4 public boards.
Experience
- Solid BiosciencesPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +23%
- Foghorn TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Areteia Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Cardurion Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
- Cerevel Therapeutics Holdings, IncPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?